Pharmaceutical Industry discussion, review, analysis, news and information. |
« Writer Wanted for PharmaGazette | Main | Introductory Post »
|
Jan25
|
 MAP Pharmaceuticals secured $25.25 million in funding. Proceeds from its Series C financing will be used primarily to advance the Phase II clinical development of the company's two lead drug candidates for the treatment of asthma and migraine. PreferredTime received $3 Million in new financing to be used to advance the sales and marketing of its pharmaceutical rep visit coordination service that was launched nationally in May 2005. |
TrackBack URL for this entry:
« Writer Wanted for PharmaGazette | Main | Introductory Post »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview